HEXA基因编码β-己糖胺酶A的α亚基,与HEXB基因编码的β亚基共同形成β-己糖胺酶A酶复合物。该酶在溶酶体中发挥关键作用,负责分解神经节苷脂GM2和其他含有N-乙酰己糖胺的糖脂。HEXA基因突变会导致β-己糖胺酶A功能缺陷,使GM2神经节苷脂在神经元中异常积累,引发泰-萨克斯病(Tay-Sachs disease),这是一种常染色体隐性遗传的溶酶体贮积症。泰-萨克斯病主要表现为进行性神经退行性变,包括运动障碍、智力衰退、失明和早夭。HEXA属于己糖胺酶基因家族,该家族成员(HEXA和HEXB)均参与糖脂代谢,通过水解糖链末端的N-乙酰己糖胺残基参与细胞膜成分的循环。HEXA基因过表达在正常情况下较为罕见,但可能影响神经节苷脂代谢平衡;而表达降低或缺失则直接导致酶活性丧失,引发GM2神经节苷脂贮积。目前已发现超过100种HEXA基因突变类型,包括错义突变、无义突变和剪切位点突变等,这些突变通过不同机制影响酶活性或稳定性。某些HEXA基因变异(如假缺陷等位基因)可能导致酶活性部分保留,引起非典型或迟发型泰-萨克斯病。HEXA基因检测可用于携带者筛查和产前诊断,特别是在德系犹太人中该基因突变携带率较高(约1/27)。HEXA与HEXB基因产物还能组合形成β-己糖胺酶B(αβ二聚体)和S(αα二聚体)同工酶,进一步扩展其在糖脂代谢中的作用范围。
This gene encodes the alpha subunit of the lysosomal enzyme beta-hexosaminidase that, together with the cofactor GM2 activator protein, catalyzes the degradation of the ganglioside GM2, and other molecules containing terminal N-acetyl hexosamines. Beta-hexosaminidase is composed of two subunits, alpha and beta, which are encoded by separate genes. Both beta-hexosaminidase alpha and beta subunits are members of family 20 of glycosyl hydrolases. Mutations in the alpha or beta subunit genes lead to an accumulation of GM2 ganglioside in neurons and neurodegenerative disorders termed the GM2 gangliosidoses. Alpha subunit gene mutations lead to Tay-Sachs disease (GM2-gangliosidosis type I). [provided by RefSeq, Jul 2009]
Subcellular localization of HEXA (and its protein):
Gene Ontology (GO) terms for HEXA:
| Interacting Gene | Interaction | Source/Score |
| Name |
|---|
| 520 Amino sugar and nucleotide sugar metabolism [PATH:hsa00520] |
| 531 Glycosaminoglycan degradation [PATH:hsa00531] |
| 603 Glycosphingolipid biosynthesis - globo series [PATH:hsa00603] |
| 604 Glycosphingolipid biosynthesis - ganglio series [PATH:hsa00604] |
| 511 Other glycan degradation [PATH:hsa00511] |
| 4142 Lysosome [PATH:hsa04142] |
| Name |
|---|
| Chondroitin sulfate/dermatan sulfate metabolism |
| CS/DS degradation |
| Glycosaminoglycan metabolism |
| Glycosphingolipid metabolism |
| Hyaluronan metabolism |
| Hyaluronan uptake and degradation |
| Keratan sulfate degradation |
| Keratan sulfate/keratin metabolism |
| Metabolism |
| Metabolism of carbohydrates |
| Metabolism of lipids and lipoproteins |
| Sphingolipid metabolism |
| Disease | Score | NofPmids | NofSnps | Source |
| Tay-Sachs Disease | 0.470660457 | 75 | 47 | BeFree_CLINVAR_CTD_human_GAD_LHGDN_MGD_UNIPROT |
| Tay-Sachs Disease, Juvenile | 0.120271442 | 1 | 1 | BeFree_CLINVAR |
| Intellectual Disability | 0.12 | 1 | 0 | CTD_human |
| Tay-Sachs Disease, Variant B1 | 0.12 | 0 | 6 | CLINVAR |
| Gm2-Gangliosidosis, Variant B1 | 0.12 | 0 | 1 | CLINVAR |
| Sandhoff Disease | 0.005981653 | 13 | 0 | BeFree_LHGDN |
| Rheumatoid Arthritis | 0.00272435 | 1 | 0 | LHGDN |
| HIV Infections | 0.00272435 | 1 | 0 | LHGDN |
| Glioma | 0.00272435 | 1 | 0 | LHGDN |
| Huntington Disease | 0.002367032 | 1 | 0 | GAD |
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: [email protected]